A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and similar GLP-1 agonists, but without muscles loss as a potential side-effect.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded in Headache: The Journal of Head and Face Pain.

Weight loss drug Wegovy, which also goes by the name Ozempic, is responsible for slimming down celebrities such as Oprah Winfrey, threatening the profits of global junk food companies and potentially decreasing obesity rates in the US.